Martingale Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-50,878
| Closed | -$3.58M | – | 770 |
|
|
2024
Q3 | $3.58M | Sell |
50,878
-7,060
| -12% | -$496K | 0.08% | 189 |
|
|
2024
Q2 | $4.77M | Sell |
57,938
-9,666
| -14% | -$796K | 0.1% | 165 |
|
|
2024
Q1 | $5.9M | Sell |
67,604
-4,650
| -6% | -$406K | 0.12% | 153 |
|
|
2023
Q4 | $6.97M | Sell |
72,254
-9,189
| -11% | -$886K | 0.14% | 149 |
|
|
2023
Q3 | $7.21M | Sell |
81,443
-8,949
| -10% | -$792K | 0.15% | 147 |
|
|
2023
Q2 | $7.84M | Sell |
90,392
-5,417
| -6% | -$470K | 0.15% | 148 |
|
|
2023
Q1 | $9.32M | Buy |
95,809
+4,949
| +5% | +$481K | 0.18% | 147 |
|
|
2022
Q4 | $9.4M | Buy |
90,860
+7,168
| +9% | +$742K | 0.18% | 143 |
|
|
2022
Q3 | $7.1M | Buy |
83,692
+5,779
| +7% | +$490K | 0.14% | 150 |
|
|
2022
Q2 | $6.46M | Buy |
77,913
+22,447
| +40% | +$1.86M | 0.12% | 166 |
|
|
2022
Q1 | $4.28M | Buy |
55,466
+14,833
| +37% | +$1.14M | 0.06% | 189 |
|
|
2021
Q4 | $3.59M | Buy |
40,633
+17,300
| +74% | +$1.53M | 0.05% | 207 |
|
|
2021
Q3 | $1.8M | Buy |
+23,333
| New | +$1.8M | 0.02% | 336 |
|
|
2021
Q2 | – | Sell |
-10,912
| Closed | -$824K | – | 834 |
|
|
2021
Q1 | $824K | Buy |
+10,912
| New | +$824K | 0.01% | 475 |
|
|
2020
Q3 | – | Sell |
-39,763
| Closed | -$4.91M | – | 1029 |
|
|
2020
Q2 | $4.91M | Buy |
+39,763
| New | +$4.91M | 0.06% | 313 |
|